Piramal Enterprises Limited

NSE:PEL.NS

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🏦 Banking & Lending

💊 Drugstores & Retail Pharmacies

💻 Fintech

💻 Telehealth

Location

India

Market Cap

USD 3.02 B

Share Price

USD 13.43

Avg Daily Volume

617,272

Change (1 day)

0.14%

Change (1 year)

22.48%

Change (YTD)

4.10%

Piramal Enterprises Limited Operating Income Margin for the year ending March 31, 2025: 75.31%

Piramal Enterprises Limited Operating Income Margin is 75.31% for the year ending March 31, 2025, a 45.88% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Piramal Enterprises Limited Operating Income Margin for the year ending March 31, 2024 was 51.63%.
Piramal Enterprises Limited Operating Income Margin for the year ending March 31, 2022 was 65.41%, a 20.56% change year over year.
Piramal Enterprises Limited Operating Income Margin for the year ending March 31, 2021 was 54.25%, a -9.68% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Operating Income Margin	Gross Profit Margin	EBIT Margin	EBITDA Margin

NSE: PEL.NS

Piramal Enterprises Limited

CEO	Mr. Yesh Nadkarni
IPO Date	Jan. 2, 1996
Location	India
Headquarters	Piramal Ananta
Employees	13,706
Sector	🏥 Health Care
Industries Pharmaceuticals 🏦 Banking & Lending 💊 Drugstores & Retail Pharmacies 💻 Fintech 💻 Telehealth

Description

Piramal Enterprises Limited operates in financial services and pharmaceuticals businesses in India, North America, Europe, Japan, and internationally. It operates through Pharmaceuticals Manufacturing and Services, and Financial Services segments. The company provides housing finance and other financing solutions, such as private equity, structured debt, senior secured debt, construction finance, and flexi lease rental discounting to real estate sector; and funding solutions to infrastructure, renewable energy, roads, industrials, auto components, and other sectors. It also operates distressed asset investing platform that invests in equity and/or debt in assets. In addition, the company offers contract development and manufacturing solutions, including drug discovery, production, and manufacturing of active pharmaceutical ingredients and formulations; and inhalation and injectable anaesthesia, injectable pain, antibiotics, and other medications, as well as intrathecal spasticity management drugs. Further, it provides over-the-counter products comprising analgesics, skin care, kids' wellness, digestives, women's health, disinfectant, Covifind, and hygiene and protection products, as well as vitamins, minerals, and supplements primarily under the Saridon, Lacto Calamine, Little's, I-Pill, Supradyn, Polycrol, Triactiv, Ourdaily, Pulse Oximeters, and Tetmosol brands. The company was formerly known as Piramal Healthcare Limited and changed its name to Piramal Enterprises Limited in July 2012. Piramal Enterprises Limited was incorporated in 1947 and is based in Mumbai, India.